 | • レポートコード：B-GIR08C1833 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ドルテグラビルの世界市場について調べ、まとめました。種類別セグメントは、10mg錠、50mg錠等、用途別セグメントは、潜在的曝露後のHIV感染予防、その他等に区分しました。ドルテグラビルの世界市場概観、企業動向、企業別ドルテグラビルシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ドルテグラビルの市場概観 ・ドルテグラビルの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ドルテグラビルの企業別販売動向、市場シェア、市場集中度、競争動向 ・ドルテグラビルの世界市場規模 ・ドルテグラビルの北米市場分析（アメリカ、カナダ、メキシコ等） ・ドルテグラビルのアメリカ市場規模推移 ・ドルテグラビルのカナダ市場規模推移 ・ドルテグラビルのメキシコ市場規模推移 ・ドルテグラビルのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ドルテグラビルのドイツ市場規模推移 ・ドルテグラビルのイギリス市場規模推移 ・ドルテグラビルのロシア市場規模推移 ・ドルテグラビルのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ドルテグラビルの日本市場規模推移 ・ドルテグラビルの中国市場規模推移 ・ドルテグラビルの韓国市場規模推移 ・ドルテグラビルのインド市場規模推移 ・ドルテグラビルの東南アジア市場規模推移 ・ドルテグラビルの南米市場分析（ブラジル、アルゼンチン等） ・ドルテグラビルの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ドルテグラビルの種類別分析/販売量、売上、市場シェア（10mg錠、50mg錠） ・ドルテグラビルの用途別分析/市場規模（潜在的曝露後のHIV感染予防、その他） ・ドルテグラビルの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ドルテグラビルの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Dolutegravir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dolutegravir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
10mg Tablets
50mg Tablets
Market Segment by Applications, can be divided into
Prevent HIV Infection Following Potential Exposure
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dolutegravir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dolutegravir, with price, sales, revenue and global market share of Dolutegravir in 2017 and 2018.
Chapter 3, the Dolutegravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dolutegravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dolutegravir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dolutegravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dolutegravir Introduction
1.2 Market Analysis by Type
1.2.1 10mg Tablets
1.2.2 50mg Tablets
1.3 Market Analysis by Applications
1.3.1 Prevent HIV Infection Following Potential Exposure
1.3.2 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ViiV Healthcare (GSK)
2.1.1 Business Overview
2.1.2 Dolutegravir Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shanghai Desano Pharmaceuticals
2.2.1 Business Overview
2.2.2 Dolutegravir Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Dolutegravir Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Aurobindo Pharma
2.4.1 Business Overview
2.4.2 Dolutegravir Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 LAURUS Labs
2.5.1 Business Overview
2.5.2 Dolutegravir Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Adcock Ingram Limited
2.6.1 Business Overview
2.6.2 Dolutegravir Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dolutegravir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Dolutegravir Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Dolutegravir Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Dolutegravir Manufacturer Market Share in 2018
3.3.2 Top 6 Dolutegravir Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Dolutegravir Market Analysis by Regions
4.1 Global Dolutegravir Sales, Revenue and Market Share by Regions
4.1.1 Global Dolutegravir Sales and Market Share by Regions (2014-2019)
4.1.2 Global Dolutegravir Revenue and Market Share by Regions (2014-2019)
4.2 North America Dolutegravir Sales and Growth Rate (2014-2019)
4.3 Europe Dolutegravir Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)
4.5 South America Dolutegravir Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)
5 North America Dolutegravir by Country
5.1 North America Dolutegravir Sales, Revenue and Market Share by Country
5.1.1 North America Dolutegravir Sales and Market Share by Country (2014-2019)
5.1.2 North America Dolutegravir Revenue and Market Share by Country (2014-2019)
5.2 United States Dolutegravir Sales and Growth Rate (2014-2019)
5.3 Canada Dolutegravir Sales and Growth Rate (2014-2019)
5.4 Mexico Dolutegravir Sales and Growth Rate (2014-2019)
6 Europe Dolutegravir by Country
6.1 Europe Dolutegravir Sales, Revenue and Market Share by Country
6.1.1 Europe Dolutegravir Sales and Market Share by Country (2014-2019)
6.1.2 Europe Dolutegravir Revenue and Market Share by Country (2014-2019)
6.2 Germany Dolutegravir Sales and Growth Rate (2014-2019)
6.3 UK Dolutegravir Sales and Growth Rate (2014-2019)
6.4 France Dolutegravir Sales and Growth Rate (2014-2019)
6.5 Russia Dolutegravir Sales and Growth Rate (2014-2019)
6.6 Italy Dolutegravir Sales and Growth Rate (2014-2019)
7 Asia-Pacific Dolutegravir by Country
7.1 Asia-Pacific Dolutegravir Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dolutegravir Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Dolutegravir Revenue and Market Share by Country (2014-2019)
7.2 China Dolutegravir Sales and Growth Rate (2014-2019)
7.3 Japan Dolutegravir Sales and Growth Rate (2014-2019)
7.4 Korea Dolutegravir Sales and Growth Rate (2014-2019)
7.5 India Dolutegravir Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)
8 South America Dolutegravir by Country
8.1 South America Dolutegravir Sales, Revenue and Market Share by Country
8.1.1 South America Dolutegravir Sales and Market Share by Country (2014-2019)
8.1.2 South America Dolutegravir Revenue and Market Share by Country (2014-2019)
8.2 Brazil Dolutegravir Sales and Growth Rate (2014-2019)
8.3 Argentina Dolutegravir Sales and Growth Rate (2014-2019)
8.4 Colombia Dolutegravir Sales and Growth Rate (2014-2019)
9 Middle East and Africa Dolutegravir by Countries
9.1 Middle East and Africa Dolutegravir Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dolutegravir Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Dolutegravir Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)
9.3 Turkey Dolutegravir Sales and Growth Rate (2014-2019)
9.4 Egypt Dolutegravir Sales and Growth Rate (2014-2019)
9.5 Nigeria Dolutegravir Sales and Growth Rate (2014-2019)
9.6 South Africa Dolutegravir Sales and Growth Rate (2014-2019)
10 Global Dolutegravir Market Segment by Type
10.1 Global Dolutegravir Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Dolutegravir Sales and Market Share by Type (2014-2019)
10.1.2 Global Dolutegravir Revenue and Market Share by Type (2014-2019)
10.2 10mg Tablets Sales Growth and Price
10.2.1 Global 10mg Tablets Sales Growth (2014-2019)
10.2.2 Global 10mg Tablets Price (2014-2019)
10.3 50mg Tablets Sales Growth and Price
10.3.1 Global 50mg Tablets Sales Growth (2014-2019)
10.3.2 Global 50mg Tablets Price (2014-2019)
11 Global Dolutegravir Market Segment by Application
11.1 Global Dolutegravir Sales Market Share by Application (2014-2019)
11.2 Prevent HIV Infection Following Potential Exposure Sales Growth (2014-2019)
11.3 Other Sales Growth (2014-2019)
12 Dolutegravir Market Forecast (2019-2024)
12.1 Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)
12.2 Dolutegravir Market Forecast by Regions (2019-2024)
12.2.1 North America Dolutegravir Market Forecast (2019-2024)
12.2.2 Europe Dolutegravir Market Forecast (2019-2024)
12.2.3 Asia-Pacific Dolutegravir Market Forecast (2019-2024)
12.2.4 South America Dolutegravir Market Forecast (2019-2024)
12.2.5 Middle East and Africa Dolutegravir Market Forecast (2019-2024)
12.3 Dolutegravir Market Forecast by Type (2019-2024)
12.3.1 Global Dolutegravir Sales Forecast by Type (2019-2024)
12.3.2 Global Dolutegravir Market Share Forecast by Type (2019-2024)
12.4 Dolutegravir Market Forecast by Application (2019-2024)
12.4.1 Global Dolutegravir Sales Forecast by Application (2019-2024)
12.4.2 Global Dolutegravir Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Dolutegravir Picture
Table Product Specifications of Dolutegravir
Figure Global Sales Market Share of Dolutegravir by Types in 2018
Table Dolutegravir Types for Major Manufacturers
Figure 10mg Tablets Picture
Figure 50mg Tablets Picture
Figure Dolutegravir Sales Market Share by Applications in 2018
Figure Prevent HIV Infection Following Potential Exposure Picture
Figure Other Picture
Figure United States Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure France Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure UK Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure China Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure India Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Dolutegravir Revenue (Value) and Growth Rate (2014-2024)
Table ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare (GSK) Dolutegravir Type and Applications
Table ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shanghai Desano Pharmaceuticals Dolutegravir Type and Applications
Table Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Dolutegravir Type and Applications
Table Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Dolutegravir Type and Applications
Table Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table LAURUS Labs Basic Information, Manufacturing Base and Competitors
Table LAURUS Labs Dolutegravir Type and Applications
Table LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors
Table Adcock Ingram Limited Dolutegravir Type and Applications
Table Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dolutegravir Sales by Manufacturer (2017-2018)
Figure Global Dolutegravir Sales Market Share by Manufacturer in 2017
Figure Global Dolutegravir Sales Market Share by Manufacturer in 2018
Table Global Dolutegravir Revenue by Manufacturer (2017-2018)
Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2017
Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2018
Figure Top 3 Dolutegravir Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Dolutegravir Manufacturer (Revenue) Market Share in 2018
Figure Global Dolutegravir Sales and Growth Rate (2014-2019)
Figure Global Dolutegravir Revenue and Growth Rate (2014-2019)
Table Global Dolutegravir Sales by Regions (2014-2019)
Table Global Dolutegravir Sales Market Share by Regions (2014-2019)
Table Global Dolutegravir Revenue by Regions (2014-2019)
Figure Global Dolutegravir Revenue Market Share by Regions (2014-2019)
Figure Global Dolutegravir Revenue Market Share by Regions in 2018
Figure North America Dolutegravir Sales and Growth Rate (2014-2019)
Figure Europe Dolutegravir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)
Figure South America Dolutegravir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)
Figure North America Dolutegravir Revenue and Growth Rate (2014-2019)
Table North America Dolutegravir Sales by Countries (2014-2019)
Table North America Dolutegravir Sales Market Share by Countries (2014-2019)
Figure North America Dolutegravir Sales Market Share by Countries (2014-2019)
Figure North America Dolutegravir Sales Market Share by Countries in 2018
Table North America Dolutegravir Revenue by Countries (2014-2019)
Table North America Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir Revenue Market Share by Countries in 2018
Figure United States Dolutegravir Sales and Growth Rate (2014-2019)
Figure Canada Dolutegravir Sales and Growth Rate (2014-2019)
Figure Mexico Dolutegravir Sales and Growth Rate (2014-2019)
Figure Europe Dolutegravir Revenue and Growth Rate (2014-2019)
Table Europe Dolutegravir Sales by Countries (2014-2019)
Table Europe Dolutegravir Sales Market Share by Countries (2014-2019)
Table Europe Dolutegravir Revenue by Countries (2014-2019)
Figure Europe Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure Europe Dolutegravir Revenue Market Share by Countries in 2018
Figure Germany Dolutegravir Sales and Growth Rate (2014-2019)
Figure UK Dolutegravir Sales and Growth Rate (2014-2019)
Figure France Dolutegravir Sales and Growth Rate (2014-2019)
Figure Russia Dolutegravir Sales and Growth Rate (2014-2019)
Figure Italy Dolutegravir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dolutegravir Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dolutegravir Sales by Countries (2014-2019)
Table Asia-Pacific Dolutegravir Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir Sales Market Share by Countries 2018
Table Asia-Pacific Dolutegravir Revenue by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir Revenue Market Share by Countries 2018
Figure China Dolutegravir Sales and Growth Rate (2014-2019)
Figure Japan Dolutegravir Sales and Growth Rate (2014-2019)
Figure Korea Dolutegravir Sales and Growth Rate (2014-2019)
Figure India Dolutegravir Sales and Growth Rate (2014-2019)
Figure Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)
Figure South America Dolutegravir Revenue and Growth Rate (2014-2019)
Table South America Dolutegravir Sales by Countries (2014-2019)
Table South America Dolutegravir Sales Market Share by Countries (2014-2019)
Figure South America Dolutegravir Sales Market Share by Countries in 2018
Table South America Dolutegravir Revenue by Countries (2014-2019)
Table South America Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure South America Dolutegravir Revenue Market Share by Countries in 2018
Figure Brazil Dolutegravir Sales and Growth Rate (2014-2019)
Figure Argentina Dolutegravir Sales and Growth Rate (2014-2019)
Figure Colombia Dolutegravir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dolutegravir Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dolutegravir Sales by Countries (2014-2019)
Table Middle East and Africa Dolutegravir Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir Sales Market Share by Countries in 2018
Table Middle East and Africa Dolutegravir Revenue by Countries (2014-2019)
Table Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)
Figure UAE Dolutegravir Sales and Growth Rate (2014-2019)
Figure Egypt Dolutegravir Sales and Growth Rate (2014-2019)
Figure Nigeria Dolutegravir Sales and Growth Rate (2014-2019)
Figure South Africa Dolutegravir Sales and Growth Rate (2014-2019)
Table Global Dolutegravir Sales by Type (2014-2019)
Table Global Dolutegravir Sales Share by Type (2014-2019)
Table Global Dolutegravir Revenue by Type (2014-2019)
Table Global Dolutegravir Revenue Share by Type (2014-2019)
Figure Global 10mg Tablets Sales Growth (2014-2019)
Figure Global 10mg Tablets Price (2014-2019)
Figure Global 50mg Tablets Sales Growth (2014-2019)
Figure Global 50mg Tablets Price (2014-2019)
Table Global Dolutegravir Sales by Application (2014-2019)
Table Global Dolutegravir Sales Share by Application (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)
Table Global Dolutegravir Sales Forecast by Regions (2019-2024)
Table Global Dolutegravir Market Share Forecast by Regions (2019-2024)
Figure North America Sales Dolutegravir Market Forecast (2019-2024)
Figure Europe Sales Dolutegravir Market Forecast (2019-2024)
Figure Asia-Pacific Sales Dolutegravir Market Forecast (2019-2024)
Figure South America Sales Dolutegravir Market Forecast (2019-2024)
Figure Middle East and Africa Sales Dolutegravir Market Forecast (2019-2024)
Table Global Dolutegravir Sales Forecast by Type (2019-2024)
Table Global Dolutegravir Market Share Forecast by Type (2019-2024)
Table Global Dolutegravir Sales Forecast by Application (2019-2024)
Table Global Dolutegravir Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
トファシチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Tofacitinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Tofacitinib in global marke…- 世界のエルトロンボパグ錠市場2019 Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). The global Eltrombopag Tablets market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 201…
- 咽頭炎錠剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Pharyngitis Tablets is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pharyngitis Tablets in global…
- ドロネダロン塩酸塩錠の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dronedarone Hydrochloride Tablets is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dronedarone Hyd…
- タブレットの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Tablet, is a mobile computer with a touchscreen display, which is usually in color, processing circuitry, and a rechargeable battery in a single thin, flat package. Tablets are great for playing games, reading, homework and a whole lot more. The most common tablets on the market are 7 to 10 inch tab…